Don't Try This At Home: Zazzle-Created EstroGel Promo Card Fizzles With FDA
This article was originally published in The Pink Sheet Daily
Low-grade sales piece touting cost savings with Ascend Therapeutics’ product lacks risk information; it is just the seventh Rx citation by FDA this year.
You may also be interested in...
Ascend’s EstroGel Promotion Misrepresents Efficacy Compared To Other Products, US FDA Says
Professional sell sheet falsely suggests estradiol gel contains lowest effective dose of estrogen compared to other estrogen products, OPDP says in fourth “untitled” letter of 2018.
Ascend Therapeutics Inc.
Ascend Therapeutics aims to develop two non-hormone drugs delivered via hydroalcoholic gels that penetrate quickly into the skin.
False Claims Act Liability: Defendant’s Belief Claims Were False Matters, Supreme Court Finds
In unanimous decision, court backs whistleblowers’ fraud theory that SuperValu and Safeway defrauded Medicare and Medicaid by reporting higher retail prices than their discounted prices. BIO, AdvaMed and MIWG submitted amicus brief in support of the retail pharmacies.